Sector focus: Pharmaceutical companies

This is the first in a series of reports examining the tax landscape affecting a particular business sector. This report on pharmaceutical companies is prepared by KPMG. It examines:

• the tax landscape affecting the sector;
• particular transfer pricing issues;
• an in-house view of the challenges facing the tax director;
• the impact of breakthroughs in intercompany accounting;
• intellectual property and R&D issues; and
• a case study: Astellas Pharma Inc.

The contributions represent the personal views of the respective authors and do not necessarily represent the...